Viracta Therapeutics, Inc. (VIRX)
NASDAQ: VIRX · Real-Time Price · USD
0.161
+0.009 (5.79%)
At close: Nov 22, 2024, 4:00 PM
0.154
-0.007 (-4.17%)
After-hours: Nov 22, 2024, 6:37 PM EST
VIRX's stock price has decreased by -70.47% in the past year and price targets may not have had time to catch up.
Viracta Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Buy
Price Target
$5.00
Upside
+3,011.39%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
RBC Capital | RBC Capital | Buy Maintains $4 → $2 | Buy | Maintains | $4 → $2 | +1,144.56% | Nov 14, 2024 |
Leerink Partners | Leerink Partners | Buy → Hold Downgrades $5 → $3 | Buy → Hold | Downgrades | $5 → $3 | +1,766.83% | Aug 16, 2024 |
RBC Capital | RBC Capital | Buy Maintains $6 → $4 | Buy | Maintains | $6 → $4 | +2,389.11% | Aug 15, 2024 |
Oppenheimer | Oppenheimer | Buy Maintains $13 → $11 | Buy | Maintains | $13 → $11 | +6,745.05% | May 23, 2024 |
Oppenheimer | Oppenheimer | Buy Maintains $13 | Buy | Maintains | $13 | +7,989.61% | Apr 17, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +2,389.11% | Apr 16, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +2,389.11% | Mar 12, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $4 | Strong Buy | Maintains | $10 → $4 | +2,389.11% | Jan 5, 2024 |
RBC Capital | RBC Capital | Buy Maintains $7 → $6 | Buy | Maintains | $7 → $6 | +3,633.67% | Nov 10, 2023 |
RBC Capital | RBC Capital | Buy Reiterates $7 | Buy | Reiterates | $7 | +4,255.94% | Oct 5, 2023 |
RBC Capital | RBC Capital | Buy Reiterates $7 | Buy | Reiterates | $7 | +4,255.94% | Aug 15, 2023 |
SVB Securities | SVB Securities | Buy Maintains $10 → $5 | Buy | Maintains | $10 → $5 | +3,011.39% | Aug 15, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +6,122.78% | Aug 15, 2023 |
EF Hutton | EF Hutton | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +6,122.78% | Jul 31, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $33 → $10 | Strong Buy | Reiterates | $33 → $10 | +6,122.78% | Jul 5, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $35 → $33 | Strong Buy | Maintains | $35 → $33 | +20,435.16% | May 10, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.